FAQ

OXIDE was founded in October 2000 by Yasunori Furukawa, as the first company to utilize the part-time work system for national public servants.

"OXIDE" means oxide, and it originates from the research and development of optical crystal materials, which is our core technology.

Our group's mission is "Illuminate with Innovation. "
At OXIDE, we are committed to exploring the full potential of optical technology and delivering its benefits to society as swiftly and extensively as possible.
This commitment has been at the core of OXIDE's mission since its founding.

The head office is located in Hokuto City, Yamanashi Prefecture. Major R&D and production sites are in Yamanashi Prefecture and Yokohama City, Kanagawa Prefecture.

The founder and management team are primarily composed of engineers and researchers with expertise in optical materials and laser technology.
For details, please refer to the latest annual securities report.

Our group develops, manufactures, and sells optical-related products such as single crystals, optical components (optical devices), laser light sources, and optical measuring equipment.
These products are used in a wide range of fields, including semiconductor manufacturing, medical devices, measuring instruments, and communications.
For details, please visit the Business Introduction page.

Specific customers are not disclosed, but we do business with domestic and international manufacturers of semiconductor inspection equipment, medical devices, optical equipment, and research instituttions.

Our strength lies in our ability to provide high-quality, high-performance single crystals and optical products through our core technologies of single crystal growth and frequency conversion.
Since our founding, we have leveraged our single crystal growth technology to improve product performance, leading to the acquisition of new customers and mass production of products.
As a research and development-oriented company, we will continue to respond to various customer needs, provide solutions in the field of optics, and incubate promising new applications and products in that process.
For details, please refer to the Business Plan and Matters Related to Growth Potential.

Our main products include "single crystals," "optical devices," and "lasers." For details, please visit the Product Introduction page.

Financial results are typically announced within 45 days of the fiscal year-end. Please check the IR Calendar for the latest financial results announcement schedule.

Currently, we do not hold earnings briefing sessions for individual investors, but we are considering future sessions.
Q&A from earnings briefing sessions for institutional investors and analysts are disclosed the morning after the session.

The latest IR materials are posted on the "IR Information" page of our official website.

We disclose revisions to our earnings forecasts in a timely and appropriate manner, based on comprehensive judgment and in accordance with relevant laws and regulations, when there are significant changes to our business outlook.

We are working with operating profit margin and EBITDA margin as key management indicators to promote business operations with a focus on profitability and efficiency.
Our medium to long-term targets are an operating profit margin of 10% and an EBITDA margin of 20%.

April 5, 2021.

Our shares are listed on the Tokyo Stock Exchange Growth Market.

The securities code is "6521".

The fiscal year-end is the last day of February every year.

Our shareholder registry administrator is Mitsubishi UFJ Trust and Banking Corporation.
For various procedures related to shares, please contact the Securities Agency Department of the bank. For details,
please check this page.opens in new window

Our group considers returning profits to shareholders as an important management issue and has a basic policy of distributing dividends while securing internal reserves for future business development and strengthening our management base.
In line with this policy, we have not paid dividends since our establishment to date in order to enhance our retained earnings.
Given our current scale and growth stage, we believe that reinvesting in business expansion will lead to future profits for our shareholders.
Therefore, we will not pay dividends for the time being and will focus on promoting research and development and investing in facilities and human resources for business expansion.
Retained earnings will be utilized for investments in high-growth, high-profitability businesses, as well as for investments to improve efficiency and revitalize existing businesses, and for human resource development.

We do not have a shareholder benefit program.

The general shareholders' meeting is scheduled to be held around the end of May each year.
Information on the date, time, location, and attendance method will be provided in the notice of convocation and on the General Shareholders' Meeting page.

There are no specific plans at this time, but we will consider the optimal market selection for improving corporate value.

There are no specific plans at this time, but we will consider them as part of our capital policy as appropriate.

We will enhance various IR initiatives, such as factory tours for shareholders and company briefing sessions for individual investors.
We will announce these events via press release when they are scheduled.

Regarding the number of shares of our company held by our Representative Director Furukawa, he has not sold any shares since the listing.
Comparing the change report submitted on December 26, 2024, with the one submitted on December 28, 2022, the number of shares held has increased by 470,300 due to the exercise of stock options (new share acquisition rights).
The reason for the decrease in shareholding ratio in the change report submitted on December 26, 2024, is due to an increase in the total number of issued shares.
The large shareholding report submitted on December 28, 2022, stated a total of 4,956,900 issued shares.
Subsequently, due to the exercise of stock options (new share acquisition rights) by our officers and employees, the third-party allotment to KLA Corporation, the exercise of MS warrants, and stock splits, the total number of issued shares increased by 6,247,923, reaching 11,204,823 shares in the change report submitted on December 26, 2024.
On December 19, 2024, Furukawa exercised his stock options (new share acquisition rights), increasing his shareholding by 65,000 shares.
At that point, when calculating the shareholding ratio, due to the aforementioned increase in the total number of issued shares, Furukawa's shareholding ratio decreased by more than 1% from 14.25% to 12.80%.
Therefore, a change report was submitted.

Since its founding in 2000, our company has actively invested in research and development and capital expenditures to enhance corporate value.
Three years after our IPO in April 2021, we determined it important to consider not only long-term growth but also short-term profitability while maintaining an overall balance, leading to the decision to appoint Mr. Yamamoto. Mr. Yamamoto has been involved in the management of our company alongside founder Mr. Furukawa for over 15 years, serving as CFO and managing the company prudently. We have judged that Mr. Yamamoto's appointment as President is appropriate for increasing our company's corporate value going forward. *In the Q&A session of the 24th Ordinary General Shareholders' Meeting (held in May 2024), then Representative Director and President Furukawa also provided an explanation in his own words.

We resolved a third-party allotment with KLA Tencor Corporation as the allottee at a board meeting on December 15, 2023, and the payment was completed on January 5, 2024.
In response to strong funding demands, our company has established close relationships with our transaction banks and utilizes not only shareholders' equity but also borrowed funds.
To expand our funding options for the future, it was necessary to strengthen our financial structure, including improving our equity ratio, and thus we conducted a third-party allotment.
The payment amount was approximately 2.81105 billion yen.
Through this third-party allotment, our company's equity ratio increased from approximately 24% to approximately 38% (as of January 5, 2024).
KLA Tencor Corporation, the allottee, is the Japanese subsidiary of the KLA Group.
KLA is a US NASDAQ-listed company and a leading company in semiconductor inspection equipment.
(Consolidated sales in FY2022 were approximately 1.5 trillion yen, and market capitalization as of January 5, 2024, was approximately 10.7 trillion yen.) KLA highly values our optical technology, and KLA and our company have deepened our relationship as strategic partners for a long period of 18 years since KLA's capital participation in our company in 2006. Furthermore, as KLA supplies products and services to major semiconductor manufacturers worldwide, it is in a crucial position to convey to us the development guidelines for products that the semiconductor industry will need in the future.
For these reasons, we selected a KLA group company as the allottee.

Regarding the number of shares of our company held by our Representative Director Furukawa, he has not sold any shares since the listing.
Comparing the large shareholding report submitted on April 9, 2021, with the change report submitted on December 28, 2022, the number of shares held has increased by 21,000 due to the exercise of stock options (new share acquisition rights).
The reason for the decrease in shareholding ratio in the change report submitted on December 28, 2022, is due to an increase in the total number of issued shares.
The large shareholding report submitted on April 9, 2021, stated a total of 4,531,500 issued shares.
Subsequently, due to the exercise of stock options (new share acquisition rights) by our officers and employees, the total number of issued shares increased by 425,400, reaching 4,956,900 shares in the change report submitted on December 28, 2022.
On December 21, 2022, Furukawa exercised his stock options (new share acquisition rights), increasing his shareholding by 10,500 shares.
At that point, when calculating the shareholding ratio, due to the aforementioned increase in the total number of issued shares, Furukawa's shareholding ratio decreased by more than 1% from 15.42% to 14.25%. Therefore, a change report was submitted.

Furukawa conducted a sale of our company's shares at the time of our Initial Public Offering (IPO) with the aim of increasing the liquidity of our shares in the market.
The Corporate Governance Report dated June 1, 2021, reflects this sale at the time of the IPO, and no additional sales have been made in the market.
Furthermore, due to the exercise of some of his stock options on April 22, 2021, his share